ClinicalMetric / Countries / Czech Republic / c3 glomerulopathy c3g
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

c3 glomerulopathy c3g Clinical Trials in Czech Republic

Active clinical trials for c3 glomerulopathy c3g with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (1)

NCT07483827 Phase 1
Recruiting

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

Enrollment
39 pts
Country
🇨🇿 Czech Republic
eleva GmbH
View Trial →

Frequently Asked Questions

How many c3 glomerulopathy c3g clinical trials are active in Czech Republic?
There are currently 1 active clinical trials for c3 glomerulopathy c3g with sites in Czech Republic, of which 1 are actively recruiting patients.
How can I join a c3 glomerulopathy c3g clinical trial in Czech Republic?
To join a c3 glomerulopathy c3g clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are c3 glomerulopathy c3g trials in Czech Republic?
Active c3 glomerulopathy c3g trials in Czech Republic span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global c3 glomerulopathy c3g Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology